Recurrence Patterns and Outcomes of Salvage Surgery in Cases of Non-Curative Endoscopic Submucosal Dissection without Additional Radical Surgery for Early Gastric Cancer.


Journal

Digestion
ISSN: 1421-9867
Titre abrégé: Digestion
Pays: Switzerland
ID NLM: 0150472

Informations de publication

Date de publication:
2019
Historique:
pubmed: 17 12 2018
medline: 10 4 2019
entrez: 17 12 2018
Statut: ppublish

Résumé

The outcomes of salvage surgery for recurrence after non-curative endoscopic submucosal dissection (ESD) without additional radical surgery for early gastric cancer (EGC) remain unclear. We determined the recurrence patterns and outcomes of salvage surgery in such cases using data from a multicenter, retrospective study. Of 15,785 patients who underwent ESD for EGC at 19 participating institutions between January 2000 and August 2011, 1,969 failed to meet the current curative criteria after ESD. Of these, 905 patients received no additional treatment. We evaluated the pattern of recurrence, clinical course after salvage surgery, and long-term survival rate for these patients. Over a median 64-month follow-up period, recurrence was detected in 27 patients. Two patients with missing data were excluded. Three, seven, and 15 (60%) patients showed intragastric relapse, regional lymph node metastasis, and distant metastasis, respectively. The first line of treatment for recurrence in 1, 7, 6, and 11 patients was endoscopic treatment, salvage surgery, chemotherapy, and best supportive care, respectively. One patient survived without recurrence for 31 months after salvage surgery, one died of acute myocardial infarction 1 month after salvage surgery, and 5 showed recurrence at 0, 2, 3, 5, and 30 months after salvage surgery and eventually succumbed to the disease. The median survival times for all patients with recurrence and the 7 patients who underwent salvage surgery were 5 months after recurrence and 7 months after salvage surgery, respectively. The survival rate after salvage surgery for recurrence after non-curative ESD without additional radical surgery for EGC is quite low, with distant metastasis being the most common recurrence pattern in these cases.

Sections du résumé

BACKGROUND/AIMS OBJECTIVE
The outcomes of salvage surgery for recurrence after non-curative endoscopic submucosal dissection (ESD) without additional radical surgery for early gastric cancer (EGC) remain unclear. We determined the recurrence patterns and outcomes of salvage surgery in such cases using data from a multicenter, retrospective study.
METHODS METHODS
Of 15,785 patients who underwent ESD for EGC at 19 participating institutions between January 2000 and August 2011, 1,969 failed to meet the current curative criteria after ESD. Of these, 905 patients received no additional treatment. We evaluated the pattern of recurrence, clinical course after salvage surgery, and long-term survival rate for these patients.
RESULTS RESULTS
Over a median 64-month follow-up period, recurrence was detected in 27 patients. Two patients with missing data were excluded. Three, seven, and 15 (60%) patients showed intragastric relapse, regional lymph node metastasis, and distant metastasis, respectively. The first line of treatment for recurrence in 1, 7, 6, and 11 patients was endoscopic treatment, salvage surgery, chemotherapy, and best supportive care, respectively. One patient survived without recurrence for 31 months after salvage surgery, one died of acute myocardial infarction 1 month after salvage surgery, and 5 showed recurrence at 0, 2, 3, 5, and 30 months after salvage surgery and eventually succumbed to the disease. The median survival times for all patients with recurrence and the 7 patients who underwent salvage surgery were 5 months after recurrence and 7 months after salvage surgery, respectively.
CONCLUSION CONCLUSIONS
The survival rate after salvage surgery for recurrence after non-curative ESD without additional radical surgery for EGC is quite low, with distant metastasis being the most common recurrence pattern in these cases.

Identifiants

pubmed: 30554228
pii: 000494413
doi: 10.1159/000494413
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-58

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

Kohei Takizawa (K)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan, k.takizawa@scchr.jp.

Waku Hatta (W)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Takuji Gotoda (T)

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.

Noboru Kawata (N)

Division of Endoscopy, Shizuoka Cancer Center, Shizuoka, Japan.

Masahiro Nakagawa (M)

Division of Endoscopy, Hiroshima City Hospital, Hiroshima, Japan.

Akiko Takahashi (A)

Division of Endoscopy, Saku Central Hospital Advanced Care Center, Nagano, Japan.

Mitsuru Esaki (M)

Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
Department of Gastroenterology, Kitakyushu Municipal Medical Center, Fukuoka, Japan.

Akira Mitoro (A)

Department of Gastroenterology and Endocrinology and Metabolism, Nara Medical University, Nara, Japan.

Shinya Yamada (S)

Department of Gastroenterology and Hepatology, Japanese Red Cross Society Kyoto Daiichi Hospital, Kyoto, Japan.

Keiko Tanaka (K)

Department of Gastroenterology, Shinshu University School of Medicine, Nagano, Japan.

Mitsuru Matsuda (M)

Department of Internal Medicine, Toyama Prefectural Central Hospital, Toyama, Japan.

Jun Takada (J)

Department of Gastroenterology, Gifu University Graduate School of Medicine, Gifu, Japan.

Shiro Oka (S)

Department of Gastroenterology and Metabolism, Hiroshima University Hospital, Hiroshima, Japan.

Hirotaka Ito (H)

Department of Gastroenterology, Osaki Citizen Hospital, Osaki, Japan.

Ken Ohnita (K)

Department of Gastroenterology and Hepatology, Nagasaki University Hospital, Nagasaki, Japan.

Ryo Shimoda (R)

Department of Internal Medicine and Gastrointestinal Endoscopy, Saga Medical School, Saga, Japan.

Shu Hoteya (S)

Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan.

Tsuneo Oyama (T)

Division of Endoscopy, Saku Central Hospital Advanced Care Center, Nagano, Japan.

Tooru Shimosegawa (T)

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH